Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2353)	12/20/2000 11:32:49 AM
From: tuck	Read Replies (1) \| Respond to of 52153

Peter, Shall we discuss our biotech bottom indicators? I'll bet you have a pet set of 'em. Doing my "environmental scanning" this morning, I see a number of small cappers without a big late-stage compound -- but with quality science -- are trading at new lows: CRIS, MCDE, RZYM, and VLTS are among them. Which brings me to the question: Have you observed a pattern in bear markets in which small cap biotechs have bottomed before the large caps or vice versa? Or something else? Cheers, Tuck

To: Biomaven who wrote (2353)	12/23/2000 11:55:54 PM
From: Scott H. Davis	Respond to of 52153

RE: <<Here's a Depressing abstract>> Not too surprising from my perspective. I've been a been a clinical analyst for about 18 years & long term Americac Sociaty for Health System Pharmacists. We have a major problem with anti-microbial resistance due to sloppy perscribing. How many times do doc's perscribe when the have not done a culture & sensitivity or even verifying by other means that they are dealing with a bacteria rather than a virus? Vanco is fast loosing it place as the last resort due to doc's ignoring FDA guidlines. I was very glad when they placed restrictions on DISPENSING it's replacement in cases where the indication & lab results did not meet the FDA protocol. One initiative that will help is incentives for docs to enter orders via electronic systms with artificial Rx inteligance. The institutes of Medicine report is causing a group of major employers/healthcare plan funders to increasingly work with health systems that have systms in place to reduce preventable medication errors. The link is to an article in the Aug 15 AJHP, where one of the three stratedies was physician order entry. Interesting point. Most doc enter orders they way they did in the 1700 - handwritten on paper, sometimes legibly. ashp.org I'm working with Sutter in Sacramento CA to integrate Sunrise Clinical Manager, which features Knowledge Based Orders (drug\drug, allergy & food interaction checking, dose range checking, dose vs lab results checking..) for doc & nurses with their pharmacy system. A key driver there is a Calif reg requiring physician order entry by 2005. Hope more states pass similar regs. FYI Scott